Retour
Fourchette du Jour
48,14 €
50,37 €
Fourchette 52 Semaines
1,87 €
50,37 €
Volume
2 422 504
Moyenne 50J / 200J
39,67 €
/
20,49 €
Clôture Précédente
49,61 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -50,7 | 0,4 |
| P/B | 13,0 | 2,9 |
| ROE % | -29,6 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
55,67 €
+11.3%
Low: 35,00 €
High: 70,00 €
BPA Prévisionnel
-1,18 €
CA Est.
960000
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-1,63 €
-1,63 € – -1,63 €
|
41 M | 2 |
| FY2028 |
-1,77 €
-2,32 € – -1,18 €
|
7,9 M | 7 |
| FY2027 |
-1,42 €
-1,75 € – -0,93 €
|
5,8 M | 8 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -70,06M
PEG of 0,42 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-29,56%
ROIC-22,00%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio23,14
Interest Coverage0,00
Valorisation
P/E Ratio
-50,69
P/B Ratio13,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -88,85M |
| ROE | -29,56% | ROA | -24,41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -70,06M |
| ROIC | -22,00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 23,14 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -50,69 | P/B Ratio | 13,02 |
| P/S Ratio | N/A | PEG Ratio | 0,42 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,50B | Enterprise Value | 4,34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 1,00M | 0,0 |
| Net Income | -88,85M | -90,21M | -60,35M | -50,16M | -29,35M |
| EPS (Diluted) | -1,12 | -1,27 | -1,67 | -1,98 | -1,61 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 1,00M | 0,0 |
| Operating Income | -101,87M | -102,56M | -62,03M | -49,86M | -37,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 363,93M | 268,52M | 287,03M | 168,07M | 92,29M |
| Total Liabilities | 18,06M | 13,15M | 10,08M | 7,77M | 23,70M |
| Shareholders' Equity | 345,87M | 255,37M | 276,94M | 160,30M | 68,59M |
| Total Debt | 1,35M | 603 000,0 | 1,21M | 0,0 | 12,88M |
| Cash & Equivalents | 161,44M | 79,93M | 143,24M | 47,70M | 74,85M |
| Current Assets | 362,11M | 267,43M | 285,19M | 166,93M | 90,87M |
| Current Liabilities | 15,65M | 11,94M | 8,47M | 6,82M | 22,82M |